LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Prepaid Expense
LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Prepaid Expense of -$350.00 thousand for the 9-month period ending 2021-02-28, per its 10-Q filed 2021-04-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2021-04-08
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense for the quarter ending 2021-02-28 was $1.19M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense for the quarter ending 2020-11-29 was -$186.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense for the quarter ending 2020-08-30 was -$1.35M, a 211.36% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense for the quarter ending 2020-05-31 was $7.37M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense for fiscal 2020 was $6.82M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense for fiscal 2019 was -$1.60M, a 140.16% decline from fiscal 2018.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense for fiscal 2018 was $3.99M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in prepaid expense for fiscal 2017 was -$1.04M.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|---|
| 2021-02-28 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | $1.00M derived: sum of 2 quarters · filed 2021-04-08 | -$350.00K 10-Q · filed 2021-04-08 | $7.02M derived: sum of 4 quarters · filed 2021-04-08 | ||
| 2020-11-29 | -$186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | -$1.54M 10-Q · filed 2021-01-07 | $5.83M derived: sum of 3 quarters · filed 2021-01-07 | $4.72M derived: sum of 4 quarters · filed 2021-04-08 | ||
| 2020-08-30 | -$1.35M 10-Q · filed 2020-10-07 | $6.01M derived: sum of 2 quarters · filed 2020-10-07 | $4.91M derived: sum of 3 quarters · filed 2021-04-08 | $4.25M derived: sum of 4 quarters · filed 2021-04-08 | ||
| 2020-05-31 | $7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $6.26M derived: sum of 2 quarters · filed 2021-04-08 | $5.60M derived: sum of 3 quarters · filed 2021-04-08 | $6.82M 10-K · filed 2020-08-14 | ||
| 2020-02-23 | -$1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | -$1.77M derived: sum of 2 quarters · filed 2021-04-08 | -$551.00K 10-Q · filed 2021-04-08 | -$1.09M derived: sum of 4 quarters · filed 2021-04-08 | ||
| 2019-11-24 | -$661.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | $554.00K 10-Q · filed 2021-01-07 | $19.00K derived: sum of 3 quarters · filed 2021-01-07 | $1.22M derived: sum of 4 quarters · filed 2021-01-07 | ||
| 2019-08-25 | $1.22M 10-Q · filed 2020-10-07 | $680.00K derived: sum of 2 quarters · filed 2020-10-07 | $1.88M derived: sum of 3 quarters · filed 2020-10-07 | -$749.00K derived: sum of 4 quarters · filed 2020-10-07 | ||
| 2019-05-26 | -$535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $666.00K derived: sum of 2 quarters · filed 2020-08-14 | -$1.96M derived: sum of 3 quarters · filed 2020-08-14 | -$1.60M 10-K · filed 2020-08-14 | ||
| 2019-02-24 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | -$1.43M derived: sum of 2 quarters · filed 2020-04-03 | -$1.07M 10-Q · filed 2020-04-03 | -$955.00K derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2018-11-25 | -$2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | -$2.27M 10-Q · filed 2020-01-02 | -$2.16M derived: sum of 3 quarters · filed 2020-08-14 | $816.00K derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2018-08-26 | $363.00K 10-Q · filed 2019-10-03 | $474.00K derived: sum of 2 quarters · filed 2020-08-14 | $3.45M derived: sum of 3 quarters · filed 2020-08-14 | $3.51M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2018-05-27 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $3.08M derived: sum of 2 quarters · filed 2020-08-14 | $3.15M derived: sum of 3 quarters · filed 2020-08-14 | $3.99M 10-K · filed 2020-08-14 | ||
| 2018-02-25 | $2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-04 | $3.04M derived: sum of 2 quarters · filed 2019-04-04 | $3.88M 10-Q · filed 2019-04-04 | $2.70M derived: sum of 4 quarters · filed 2019-08-01 | ||
| 2017-11-26 | $63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07 | $904.00K 10-Q · filed 2019-01-07 | -$272.00K derived: sum of 3 quarters · filed 2019-08-01 | $531.00K derived: sum of 4 quarters · filed 2019-08-01 | ||
| 2017-08-27 | $841.00K 10-Q · filed 2018-10-05 | -$335.00K derived: sum of 2 quarters · filed 2019-08-01 | $468.00K derived: sum of 3 quarters · filed 2019-08-01 | -$545.00K derived: sum of 4 quarters · filed 2019-08-01 | ||
| 2017-05-28 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | -$373.00K derived: sum of 2 quarters · filed 2019-08-01 | -$1.39M derived: sum of 3 quarters · filed 2019-08-01 | -$1.04M 10-K · filed 2019-08-01 | ||
| 2017-02-26 | $803.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | -$210.00K derived: sum of 2 quarters · filed 2018-04-05 | $137.00K 10-Q · filed 2018-04-05 | -$842.00K derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2016-11-27 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | -$666.00K 10-Q · filed 2018-01-05 | -$1.65M derived: sum of 3 quarters · filed 2018-08-09 | -$4.09M derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2016-08-28 | $347.00K 10-Q · filed 2017-09-28 | -$632.00K derived: sum of 2 quarters · filed 2018-08-09 | -$3.08M derived: sum of 3 quarters · filed 2018-08-09 | -$348.00K derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2016-05-29 | -$979.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | -$3.43M derived: sum of 2 quarters · filed 2018-08-09 | -$695.00K derived: sum of 3 quarters · filed 2018-08-09 | -$965.00K 10-K · filed 2018-08-09 | ||
| 2016-02-28 | -$2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07 | $284.00K derived: sum of 2 quarters · filed 2017-04-07 | $14.00K 10-Q · filed 2017-04-07 | -$419.00K 10-Q · filed 2016-03-30 | ||
| 2015-11-29 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-05 | $2.46M 10-Q · filed 2017-01-05 | $2.09M 10-Q · filed 2016-01-07 | |||
| 2015-08-30 | -$270.00K 10-Q · filed 2016-09-29 | |||||
| 2015-05-31 | -$177.00K 10-K/A · filed 2018-03-15 | |||||
| 2015-03-01 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | $441.00K 10-Q · filed 2016-03-30 | ||||
| 2014-11-30 | -$2.06M 10-Q · filed 2016-01-07 | |||||
| 2014-05-25 | -$4.71M 10-K · filed 2016-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |